Letter: The Climate Of Fraud

Candace Pert begins her recent Commentary (The Scientist, April 2, 1990, page 18) with the hypotheses that it is "the one-in-a-million scientist who fabricates data" and that "the overwhelming majority of outright deceptions . . . is quickly revealed." From this she continues that overattention to the possibility of fraud generates a "witch-hunting climate," which may make reviewers ruthlessly skeptical of "the new, unexpected discoveries that make for real scientific progress." There is, howe

Written byDonald Forsdyke
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Candace Pert begins her recent Commentary (The Scientist, April 2, 1990, page 18) with the hypotheses that it is "the one-in-a-million scientist who fabricates data" and that "the overwhelming majority of outright deceptions . . . is quickly revealed." From this she continues that overattention to the possibility of fraud generates a "witch-hunting climate," which may make reviewers ruthlessly skeptical of "the new, unexpected discoveries that make for real scientific progress."

There is, however, an alternative hypothesis, which leads to startlingly different conclusions: that fabrication of data is very common and that the overwhelming majority of deceptions goes undetected.

From this it follows that many of those whose careers are advan-ced by cheating may become the very reviewers whose "defense of the status quo" Pert objects to, "particularly if it has relevance to" their "own work, reputation and livelihood." Perhaps it is not "emotional" bias that affects their perceptions and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies